Entrada Therapeutics GAAP EPS of -$0.94 beats by $0.30, revenue of $1.3M misses by $6.11M

Entrada Therapeutics reported a GAAP EPS of -$0.94, beating estimates, but its revenue of $1.3M missed expectations.